Effects of dietary fibers on disturbances clustered in the metabolic syndrome

Journal of Nutritional Biochemistry

Volumn 19, Issue 2, 2008, Pages 71-84

  Galisteo, Milagros ^a   Duarte, Juan ^a   Zarzuelo, Antonio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cardiovascular disease; Dietary fiber; Inflammatory markers; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; ISPAGULA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOKINE PRODUCTION; DIETARY FIBER; DISEASE MARKER; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GRAIN; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

DIETARY FIBER; HUMANS; METABOLIC SYNDROME X;

EID: 37549071092     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.02.009     Document Type: Review

References (143)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
3. Meigs J.B., Wilson P.W., Nathan D.M., D'Agostino Sr. R.B., Williams K., and Haffner S.M. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
4. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 27 (2004) 2444-2449
5. Cook S., Weitzman M., Auinger P., Nguyen M., and Dietz W.H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157 (2003) 821-827
6. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
7. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
8. Davy B.M., and Melby C.L. The effect of fiber-rich carbohydrates on features of syndrome X. J Am Diet Assoc 103 (2003) 86-96
9. Delzenne N.M., and Cani P.D. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8 (2005) 636-640
10. Venn B.J., and Mann J.I. Cereal grains, legumes and diabetes. Eur J Clin Nutr 58 (2004) 1443-1461
11. McKeown N.M., Meigs J.B., Liu S., Saltzman E., Wilson P.W., and Jacques P.F. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 27 (2004) 538-546
12. Sahyoun N.R., Jacques P.F., Zhang X.L., Juan W., and McKeown N.M. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 83 (2006) 124-131
13. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
14. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
15. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
16. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., Kahn R.A., American Heart Association, et al. Clinical management of metabolic syndrome report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
17. Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
18. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
19. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., and Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 107 (2006) 28-36
20. Lorincz A.M., and Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 13 (2006) 279-292
21. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation (1999), World Health Organization, Geneva
22. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
23. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
24. Alberti K.G.M.M., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
25. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., American Heart Association, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
26. Anderson P.J., Critchley J.A., Chan J.C., Cockram C.S., Lee Z.S., Thomas G.N., et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 25 (2001) 1782-1788
27. Ukkola O., and Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Ann Med 33 (2001) 79-90
28. Pickup J.C., Mattock M.B., Chusney G.D., and Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
29. Dandona P., Aljada A., Chaudhuri A., Mohanty P., and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
30. Sonnenberg G.E., Krakower G.R., and Kissebah A.H. A novel pathway to the manifestations of metabolic syndrome. Obes Res 12 (2004) 180-186
31. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
32. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
33. Matsushita K., Ishikawa T., Sumita S., Kobayashi T., Ogawa H., Inoue N., et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 26 (2006) 871-876
34. DeVries J.W. On defining dietary fibre. Proc Nutr Soc 62 (2003) 37-43
35. American Association of Cereal Chemists. The definition of dietary fiber. Cereal Foods World 46 (2001) 112-129
36. James S.L., Muir J.G., Curtis S.L., and Gibson P.R. Clinical perspectives. Dietary fiber: a roughage guide. Intern Med J 33 (2003) 291-296
37. Jones J.R., Lineback D.M., and Levine M.J. Dietary reference intakes. Implications for fiber labelling and consumption: a summary of the International Life Sciences Institute North America Fiber Workshop, June 1-2, 2004, Washington, DC. Nutr Rev 64 (2006) 31-38
38. Marlett J.A., McBurney M.I., Slavin J.L., and American Dietetic Association. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 102 (2002) 993-1000
39. Cummings J.H., Bingham S.A., Heaton K.W., and Eastwood M.A. Fecal weight, colon cancer risk and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 103 (1992) 1783-1789
40. Howe G.R., Benito E., Castelleto R., Cornee J., Esteve J., Gallagher R.P., et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 84 (1992) 1887-1896
41. Prentice R.L. Future possibilities in the prevention of breast cancer: fat and fiber and breast cancer research. Breast Cancer Res 2 (2000) 268-276
42. Suter P.M. Carbohydrates and dietary fiber. Handb Exp Pharmacol 170 (2005) 231-261
43. Frayn K.N. Visceral fat and insulin resistance-causative or correlative?. Br J Nutr 83 (2000) S71-S77
44. Reaven G.M. Diet and syndrome X. Curr Atheroscler Rep 2 (2000) 503-507
45. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6 (1998) 51S-209S
46. Slavin J.L. Dietary fiber and body weight. Nutrition 21 (2005) 411-418
47. Koh-Banerjee P., and Rimm E.B. Whole grain consumption and weight gain: a review of the epidemiological evidence, potential mechanisms and opportunities for future research. Proc Nutr Soc 62 (2003) 25-29
48. Rigaud D., Ryttig K.R., Angel L.A., and Apfelbaum M. Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial. Int J Obes 14 (1990) 763-769
49. Solum T.T., Ryttig K.R., Solum E., and Larsen S. The influence of a high-fibre diet on body weight, serum lipids and blood pressure in slightly overweight persons. A randomized, double-blind, placebo-controlled investigation with diet and fibre tablets (DumoVital). Int J Obes 11 (1987) 67-71
50. Appleby P.M., Thorogood M., Mann J.I., and Key T.J. Low body mass index in non-meat eaters: the possible roles of animal fat, dietary fibre and alcohol. Int J Obes Relat Metab Disord 22 (1998) 454-460
51. Nelson L.H., and Tucker L.A. Diet composition related to body fat in a multivariate study of 293 men. J Am Diet Assoc 96 (1996) 771-777
52. Liu S., Willett W.C., Manson J.E., Hu F.B., Rosner B., and Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78 (2003) 920-927
53. Koh-Banerjee P., Franz M., Sampson L., Liu S., Jacobs Jr. D.R., Spiegelman D., et al. Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr 80 (2004) 1237-1245
54. Conceicao de Oliveira M., Sichieri R., and Sanchez Moura A. Weight loss associated with a daily intake of three apples or three pears among overweight women. Nutrition 19 (2003) 253-256
55. Howarth N.C., Saltzman E., and Roberts S.B. Dietary fiber and weight regulation. Nutr Rev 59 (2001) 129-139
56. Pereira M.A., and Ludwig D.S. Dietary fiber and body weight regulation. Observations and mechanisms. Pediatr Clin North Am 48 (2001) 969-980
57. Raben A., Christensen N.J., Madsen J., Holst J.J., and Astrup A. Decreased postprandial thermogenesis and fat oxidation but increased fullness after a high-fiber meal compared with a low-fiber meal. Am J Clin Nutr 59 (1994) 1386-1394
58. Roberts S.B. High-glycemic index foods, hunger and obesity: is there a connection?. Nutr Rev 58 (2000) 163-170
59. Holt S., Brand J., Soveny C., and Hansky J. Relationship of satiety to postprandial glycemic, insulin and cholecystokinin responses. Appetite 18 (1992) 129-141
60. Bourdon I., Yokoyama W., Davis P., Hudson C., Backus R., Richter D., et al. Postprandial lipid, glucose, insulin and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 69 (1999) 55-63
61. Liddle R.A. Cholecystokin cells. Annu Rev Physiol 59 (1997) 221-242
62. Cani P.D., Dewever C., and Delzenne N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation, glucagon-like peptide-1, and ghrelin, in rats. Br J Nutr 92 (2004) 521-526
63. Mazur A., Remesy C., and Demigne C. The effect of high-fibre diet on plasma lipoproteins and hormones in genetically obese Zucker rats. Eur J Clin Invest 20 (1990) 600-606
64. Oku T., Konishi F., and Hosoya N. Mechanism of inhibitory effect of unavailable carbohydrate on intestinal calcium absorption. J Nutr 112 (1982) 410-415
65. Gallaher C.M., Munion J., Hesslink Jr. R., Wise J., and Gallaher D.D. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr 130 (2000) 2753-2759
66. Galisteo M., Sanchez M., Vera R., Gonzalez M., Anguera A., Duarte J., et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr 135 (2005) 2399-2404
67. Pittler M.H., and Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 110 (2001) 724-730
68. Pittler M.H., and Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 79 (2004) 529-536
69. Costacou T., and Mayer-Davis E.J. Nutrition and prevention of type 2 diabetes. Annu Rev Nutr 23 (2003) 147-170
70. Salmeron J., Ascherio A., Rimm E.B., Colditz G.A., Spiegelman D., Jenkins D.J., et al. Dietary fiber, glycemic load, and the risk of NIDDM in men. Diabetes Care 20 (1997) 545-550
71. Liu S., Manson J.E., Stampfer M.J., Rexrode K.M., Hu F.B., Rimm E.B., et al. Whole grain consumption and risk of ischemic stroke in women: a prospective study. JAMA 284 (2000) 1534-1540
72. Fung T.T., Hu F.B., Pereira M.A., Liu S., Stampfer M.J., Colditz G.A., et al. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 76 (2002) 535-540
73. Ylonen K., Saloranta C., Kronberg-Kippila C., Groop L., Aro A., and Virtanen M. et al. Associations of dietary fiber with glucose metabolism in nondiabetic relatives of subjects with type 2 diabetes: the Botnia Dietary Study. Diabetes Care 26 (2003) 1979-1985
74. Hanai H., Ikuma M., Sato Y., Iida T., Hosoda Y., Matsushita I., et al. Long-term effects of water-soluble corn bran hemicellulose on glucose tolerance in obese and non-obese patients: improved insulin sensitivity and glucose metabolism in obese subjects. Biosci Biotechnol Biochem 61 (1997) 1358-1361
75. Anderson J.W., Allgood L.D., Turner J., Oeltgen P.R., and Daggy B.P. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 70 (1999) 466-473
76. Sierra M., Garcia J.J., Fernández N., Diez M.J., Calle A.P., Sahagun A.M., et al. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur J Clin Nutr 55 (2001) 235-243
77. Sierra M., Garcia J.J., Fernández N., Diez M.J., Calle A.P., and Farmafibra Group. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 56 (2002) 830-842
78. Cameron-Smith D., Collier G.R., and O'Dea K. Effect of soluble dietary fibre on the viscosity of gastrointestinal contents and the acute glycaemic response in the rat. Br J Nutr 71 (1994) 563-571
79. Leclere C.L., Champ M., Boillot J., Guille G., Lecannu G., Molis C., et al. Role of viscous guar gums in lowering the glycemic response after a solid meal. Am J Clin Nutr 59 (1994) 914-921
80. Song Y.J., Sawamura M., Ikeda K., Igawa S., and Yamori Y. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 27 (2000) 41-45
81. Park K.S., Ciaraldi T.P., Lindgren K., Abrams-Carter L., Mudaliar S., Nikoulina S.E., et al. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 83 (1998) 2830-2835
82. Cummings J.H., and Englyst H.N. Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 45 (1987) l243-l255
83. Jenkins D.J. Lente carbohydrate: a newer approach to the dietary management of diabetes. Diabetes Care 5 (1982) 634-641
84. Pereira M.A., Jacobs Jr. D.R., Pins J.J., Raatz S.K., Gross M.D., Slavin J.L., et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 75 (2002) 848-855
85. Esposito K., Pontillo A., Di Palo C., Giugliano F., Masella M., Marfella R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289 (2003) 1799-1804
86. McKeown N.M., Meigs J.B., Liu S., Wilson P.W., and Jacques P.F. Whole-grain intake is favourably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76 (2002) 390-398
87. Weickert M.O., Mohlig M., Schofl C., Arafat A.M., Otto B., Viehoff H., et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 29 (2006) 775-780
88. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 (2001) 790-797
89. Weickert M.O., Mohlig M., Koebnick C., Holst J.J., Namsolleck P., Ristow M., et al. Impact of cereal fibre on glucose-regulating factors. Diabetologia 48 (2005) 2343-2353
90. Kok N.N., Morgan L.M., Williams C.M., Roberfroid M.B., Thissen J.-P., and Delzenne N.M. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr 128 (1998) 1099-1103
91. Cani P.D., Neyrinck A.M., Maton N., and Delzenne N.M. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13 (2005) 1000-1007
92. Fernandez M.L. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 12 (2001) 35-40
93. Ripsin C.M., Keenan J.M., Jacobs Jr. D.R., Elmer P.J., Welch R.R., Van Horn L., et al. Oat products and lipid lowering. A meta-analysis. JAMA 267 (1992) 3317-3325
94. Brown L., Rosner B., Willett W.W., and Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69 (1999) 30-42
95. Aller R., de Luis D.A., Izaola O., La Calle F., del Olmo L., Fernandez L., et al. Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial. Diabetes Res Clin Pract 65 (2004) 7-11
96. Chen J., He J., Wildman R.P., Reynolds K., Streiffer R.H., and Whelton P.K. A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 60 (2006) 62-68
97. Chandalia M., Garg A., Lutjohann D., von Bergmann K., Grundy S.M., and Brinkley L.J. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342 (2000) 1392-1398
98. Fernandez M.L., Ruiz L.R., Conde A.K., Sun D.M., Erickson S.K., and McNamara D.J. Psyllium reduces plasma LDL in guinea pigs by altering hepatic cholesterol metabolism. J Lipid Res 36 (1995) 1128-1138
99. Fernandez M.L. Distinct mechanisms of plasma LDL lowering by dietary fiber in the guinea pig: specific effects of pectin, guar gum, and psyllium. J Lipid Res 36 (1995) 2394-2404
100. Horton J.D., Cuthbert J.A., and Spady D.K. Regulation of hepatic 7[alpha]-hydroxylase expression by dietary psyllium in the hamster. J Clin Invest 93 (1994) 2084-2092
101. Aprikian O., Busserolles J., Manach C., Mazur A., Morand C., Davicco M.J., et al. Lyophilized apple counteracts the development of hypercholesterolemia, oxidative stress, and renal dysfunction in obese Zucker rats. J Nutr 132 (2002) 1969-1976
102. Li J., Wang J., Kaneko T., Qin L.Q., and Sato A. Effects of fiber intake on the blood pressure, lipids, and heart rate in Goto Kakizaki rats. Nutrition 20 (2004) 1003-1007
103. Jeon B.S., Park J.W., Kim B.K., Kim H.K., Jung T.S., Hahm J.R., et al. Fermented mushroom milk-supplemented dietary fibre prevents the onset of obesity and hypertriglyceridaemia in Otsuka Long-Evans Tokushima fatty rats. Diabetes Obes Metab 7 (2005) 709-715
104. Kok N., Roberfroid M., Robert A., and Delzenne N. Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76 (1996) 880-891
105. van Bennekum A.M., Nguyen D.V., Schulthess G., Hauser H., and Phillips M.C. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr 94 (2005) 331-337
106. Jenkins D.J.A., Kendall C.W.C., and Vuksan V. Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr 71 (2000) 401-402
107. Ebihara K., and Schneeman B.O. Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J Nutr 119 (1989) 1100-1106
108. Liljeberg H., and Bjorck I. Effects of a low-glycaemic index spaghetti meal on glucose tolerance and lipaemia at a subsequent meal in healthy subjects. Eur J Clin Nutr 54 (2000) 24-28
109. Kok N., Roberfroid M., and Delzenne N. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 45 (1996) 1547-1550
110. Giffhorn-Katz S., and Katz N.R. Carbohydrate-dependent induction of fatty acid synthase in primary cultures of rat hepatocytes. Eur J Biochem 159 (1986) 513-518
111. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
112. Burke V., Hodgson J.M., Beilin L.J., Giangiulioi N., Rogers P., and Puddey I.B. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 38 (2001) 821-826
113. Jenkins D.J., Kendall C.W., Vuksan V., Vidgen E., Parker T., Faulkner D., et al. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 75 (2002) 834-839
114. Obata K., Ikeda K., Yamasaki M., and Yamori Y. Dietary fiber, psyllium, attenuates salt-accelerated hypertension in stroke-prone spontaneously hypertensive rats. J Hypertens 16 (1998) 1959-1964
115. He J., Streifferc R.H., Muntner P., Krousel-Wood M.A., and Whelton P.K. Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 22 (2004) 73-80
116. Whelton S.P., Hyrea A.D., Pedersen B., Yia Y., Whelton P.K., and He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 23 (2005) 475-481
117. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., et al. Insulin resistance in essential hypertension. N Engl J Med 317 (1987) 350-357
118. King D.E., Mainous A.G., Egan B.M., Woolson R.F., and Geeset M.E. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 28 (2005) 1487-1489
119. Qi L., Rimm E., Liu S., Rifai N., and Hu F.B. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28 (2005) 1022-1028
120. Neter J.E., Stam B.E., Kok F.J., Grobbee D.E., and Geleijnse J.M. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42 (2003) 878-884
121. Marckmann P. Dietary treatment of thrombogenic disorders related to the metabolic syndrome. Br J Nutr 83 (2000) S121-S126
122. Fehily A.M., Milbank J.E., Yarnell J.W., Hayes T.M., Kubiki A.J., and Eastham R.D. Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure. Am J Clin Nutr 36 (1982) 890-896
123. Yarnell J.W.G., Fehily A.M., Milbank J., Kubiki A.J., Eastham R., and Hayes T.M. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health 37 (1983) 137-140
124. Simpson H.C., Mann J.I., Chakrabarti R., Imeson J.D., Stirling Y., Tozer M., et al. Effects of high-fibre diet on haemostatic variables in diabetes. Br Med J 284 (1982) 1608
125. Fehily A.M., Burr M.L., Butland B.K., and Eastham R.D. A randomized controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen. J Epidemiol Community Health 40 (1986) 334-337
126. Djoussé L., Ellison R.C., Zhang Y., Arnett D.K., Sholinsky P., and Borecki I. Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 68 (1998) 568-575
127. Nilsson T.K., Sundell I.B., Hellsten G., and Hallman G. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables. J Intern Med 227 (1990) 267-271
128. Sundell I.B., and Ranby M. Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 23 (1993) 45-50
129. Pilgeram L.O., and Pickart L.R. Control of fibrinogen biosynthesis: the role of free fatty acid. J Artheroscler Res 8 (1968) 155-166
130. Juhan-Vague I., Thompson S.G., and Jespersen J. Involvement of hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb 13 (1993) 1865-1873
131. King D.E., Egan B.M., and Geesey M.E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92 (2003) 1335-1339
132. Ajani U.A., Ford E.S., and Mokdad A.H. Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey data. J Nutr 134 (2004) 1181-1185
133. Ma Y., Griffith J.A., Chasan-Taber L., Olendzki B.C., Jackson E., Stanek III E.J., et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83 (2006) 760-766
134. Qi L., van Dam R.M., Liu S., Franz M., Mantzoros C., and Hu F.B. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29 (2006) 207-211
135. Esposito K., Nappo F., Giugliano F., Di Palo C., Ciotola M., Barbieri M., et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78 (2003) 1135-1140
136. Qi L., Meigs J.B., Liu S., Manson J.E., Mantzoros C., and Hu F.B. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 29 (2006) 1501-1505
137. Dietrich M., and Jialal I. The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 63 (2005) 22-28
138. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., and Wadden T. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83 (1998) 2907-2910
139. King D. Dietary fiber, inflammation, and cardiovascular disease. Mol Nutr Food Res 49 (2005) 594-600
140. Patz J., Jacobsohn W.Z., Gottschalk-Sabag S., Zeides S., and Braverman D.Z. Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas. Am J Gastroenterol 91 (1996) 731-734
141. Segain J.P., Raingeard de la Bletiere D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 (2000) 397-403
142. Saemann M.D., Bohmig G.A., Osterreicher C.H., Burtscher H., Parolini O., Diakos C., et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 14 (2000) 2380-2382
143. Zapolska-Downar D., Siennicka A., Kaczmarczyk M., Kolodziej B., and Naruszewicz M. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-κB and PPARα. J Nutr Biochem 15 (2004) 220-228